Shyamal Mehta is a Neurology physician affiliated with Mayo Clinic in Arizona. OpenAlex indexes 143 publications with 2,411 citations (h-index 27).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
13400 E Shea Blvd
Scottsdale, AZ 85259
Telephone
480-301-8000Provider last certified this registry record 8 Sept 2020.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202511 payments
- Neurocrine BioSciences, Inc.Program year20251 payment
- MDD US Operations, LLCProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
94.9%Neuromuscular Blocker94.9%Onabotulinumtoxina66%Incobotulinumtoxin a34%Part B, office-administered≥36 patientsgamma-Aminobutyric Acid-ergic Agonist0.1%Baclofen100%Part D<11 patientsNervous system
4.7%Aromatic Amino Acid Decarboxylation Inhibitor2.4%Carbidopa-Levodopa56%Carbidopa-Levodopa Er35%Rytary7%Carbidopa-Levodopa-Entacapone2%Part D<11 patientsInfluenza A M2 Protein Inhibitor0.4%Amantadine100%Part D≥29 patients+ 12 more classes in this area
Cardiovascular
0.3%Beta blocker0.2%Propranolol Hcl Er100%Part D≥19 patientsalpha-Adrenergic Agonist0.1%Midodrine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Low clinical sensitivity and unexpectedly high incidence for neuropathologically diagnosed progressive supranuclear palsy
Journal of Neuropathology & Experimental Neurology
2023 - Cerebral white matter rarefaction has both neurodegenerative and vascular causes and may primarily be a distal axonopathy
Journal of Neuropathology & Experimental Neurology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Caselli, MD
Mayo Clinic in Arizona
Mark Pittelkow, MD
Mayo Clinic in Arizona
John Dibaise, MD
Mayo Clinic in Arizona
Norio Fukami, MD
Mayo Clinic in Arizona
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”